The total viral vector market sported revenues of $712.2 million in 2021, according to research published in Viral Vectors Market for Cell Therapy Market: Analysis and Opportunities, a new report by leading medical market researcher Kalorama Information. Viral vectors are altered viruses that can safely transport therapeutic products into cells and growth is forecast […]
In 2021’s most notable IVD merger and acquisition, San-Diego, CA-based Quidel announced an acquisition of Raritan, N.J.-based Ortho Clinical Diagnostics. Both companies are in Kalorama’s IVD Market “Top Tier” And they couldn’t be more different. Quidel tends to sell to the clinic, Ortho Clinical to the hospital. Quidel sells flu and respiratory infectious disease tests, […]
From In Vitro Diagnostics Business Outlook Newsletter – Subscribe Today. Zika isn’t something covered in the news much anymore but in the blood screening IVD market, it still matters. So do all the other past disease threats to a pure blood supply, and the possible future threats. New disease threats reaching the level of concern […]
The following are recent developments in Cell and Gene Therapy, from the latest issue of Cell and Gene Therapy Business Outlook Adicet Bio, based in Boston, MA, reported positive interim data from its Phase I dose escalation study of ADI-001, a gamma delta CAR T-cell therapy targeting CD20 for the treatment of B-cell non-Hodgkin’s lymphoma. […]
We keep saying it, but that is only because it remains true: China continues to be an untapped market for IVD manufacturers. It’s certainly not out of a desire to follow the crowd. As China’s rate of growth has slowed, we’ve noted that. Yet based on our global market analysis, the IVD market there remains […]
In a hybrid virtual and in-person meeting based in Atlanta, GA this year, the American Association of Clinical Chemistry met to share insights in laboratory medicine. The event coincides with the Clinical Lab Expo, which is an important showcase for IVD vendors demonstrating new products and conducting strategic presentations and commentary. About 7,500 lab professionals […]
Kalorama Information, specialists in market research data in the in vitro diagnostics market since 2001, has now published its latest (14th) edition of their comprehensive market report. The market for IVD products including instruments and reagents is $117 billion dollars. Kalorama’s 1,500 + page report is used by top companies in the industry and by prospective entrants, investors and […]
The market for DNA-based tests used for clinical diagnostic purposes has exceeded previous forecasting, due to the COVID-19 crisis. Mid 2019, Kalorama Information’s report projected the market size (all DNA-based tests, revenues to IVD companies) would reach 10.1 billion. We also estimated cancer would be the driver. Instead, Kalorama now projects that market to be […]
Diagnostic testing companies should do a better job of turning around biomarker test results for lung cancer patients, according to a survey reported at the American Society of Clinical Oncology (ASCO) annual meeting on June 4. Out of 170 clinicians polled, the vast majority (98%) said that they felt it was important to get biomarker […]
The American Association for Clinical Chemistry (AACC) released guidance on lab testing for acute kidney injury (AKI) patients that proposes new diagnostic thresholds for whether a patient has AKI with creatinine testing. One of the major recommendations is to propose that clinicians use the 20/20 AACC acute kidney injury criteria to determine whether a patient […]
Email Us: Customer Service
Phone (US): 703-778-3080
Fax: 703-778-3081
